Former Emory Healthcare Chief Data and AI Officer Joe Depa joins EY as global chief innovation officer. Learn more about his departure and new role.

Epic intensifies pursuit of interoperability, with 9 things to know: commitment to TEFCA, big health system participation, and more.

Texas maternal mortality committee skips examining cases from 2022-2023, focusing on more recent deaths for relevant policy recommendations, despite concerns.

Fosston, Minn., city council members unanimously voted on Nov. 26 to terminate an agreement that allowed Duluth, Minn.-based Essentia Health to control Fosston Hospital, something the health system ...

Health system C-suites are taking their organizations "back to the basics" next year to focus on improving quality outcomes and creating an elite patient experience. This means prioritizing a culture ...

Baxter also outlined plans to gradually increase allocations over the next several weeks, with the goal of reaching 100% allocation for several IV product codes by the end of 2024. The company has ...

Meet Dr. Amy Herold, the newly appointed chief administrative officer of Providence Queen of the Valley Medical Center in Napa, Calif. Learn about her journey ...

A former pharmacy technician at Chicago-based Lurie Children's Hospital has filed a lawsuit accusing the hospital of firing her in retaliation for reporting unsafe medication compounding practices, ...

Security officers at Rochester Regional Health now have the opportunity to become peace officers, NPR affiliate WXXI reported Nov. 25. This change comes as a result of a New York state Senate Assembly ...

Here are six recent GLP-1 studies: 1. The use of Ozempic and Wegovy reduced healthcare costs for overweight or obese patients with heart failure or atherosclerotic cardiovascular disease, according to ...

A Maryland medical malpractice attorney known for his aggressive tactics faces up to 20 years in prison after a federal jury convicted him of attempting to extort $25 million from the University of ...

Should employers, patients or insurers cover the $411 billion annual cost for GLP-1 drugs? U.S. healthcare industry grapples with this question as demand grows.